Cargando…

Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis

Sineoculis homeobox homolog (SIX) family proteins, including SIX1, SIX2, SIX3, SIX4, SIX5, and SIX6, have been implicated in the initiation and progression of breast cancer, but the role of each member in breast tumor is not fully understood. We conducted a systematic review and meta-analysis to eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Han-Xiao, Wu, Kong-Ju, Tian, Yi-Jun, Liu, Qian, Han, Na, He, Xue-Lian, Yuan, Xun, Wu, Gen Sheng, Wu, Kong-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058828/ https://www.ncbi.nlm.nih.gov/pubmed/27399099 http://dx.doi.org/10.1097/MD.0000000000004085

Ejemplares similares

Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis
por: Liu, Shuyu, et al.
Publicado: (2020)

Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis: Correlations With Detailed Pathological Findings
por: Ko, Eun Sook, et al.
Publicado: (2016)

Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer
por: Yao, Juan, et al.
Publicado: (2017)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: A protocol for meta-analysis and bioinformatics analysis
por: Xiao, Dachun, et al.
Publicado: (2021)

Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis
por: Zhao, Xiao-Bo, et al.
Publicado: (2016)

Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer
por: Jia, Yiwei, et al.
Publicado: (2023)

Association of neutrophil-to-lymphocyte ratio with clinical, pathological, radiological, laboratory features and disease outcomes of invasive breast cancer patients: A retrospective observational cohort study
por: Jadoon, Sarosh Khan, et al.
Publicado: (2023)

Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021)

Development and validation of a risk stratification nomogram for predicting prognosis in bone metastatic breast cancer: A population-based study
por: Hou, Niuniu, et al.
Publicado: (2021)

Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2– patients with metastatic breast cancer
por: Li, Jingping, et al.
Publicado: (2021)

Synergistic association of FOXP3(+) tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer: A retrospective cohort study
por: Zhao, Xia, et al.
Publicado: (2019)

Analysis of breast cancer cases according to county-level poverty status in 3.5 million rural women who participated in a breast cancer screening program of Hunan province, China from 2016 to 2018
por: Lili, Xiong, et al.
Publicado: (2020)

Clinical and sonographic features of nipple lesions
por: Cai, Siman, et al.
Publicado: (2020)

Expression and prognosis analysis of GINS subunits in human breast cancer
por: Li, Hongtao, et al.
Publicado: (2021)

The effects of case management for breast cancer patients: A protocol for systematic review and meta-analysis
por: Chai, Yong, et al.
Publicado: (2022)

Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
por: Yang, Xiaolu, et al.
Publicado: (2022)

Surgical management of breast cancer in China: A 15-year single-center retrospective study of 18,502 patients
por: Huang, Nai-si, et al.
Publicado: (2016)

Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study
por: Wang, Haiyong, et al.
Publicado: (2017)

Clinicopathologic features of single bone metastasis in breast cancer
por: Karatas, Murat, et al.
Publicado: (2021)

Imaging features of granular cell tumor in the breast: Case report
por: Zeng, Qiao, et al.
Publicado: (2020)

A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis
por: Xing, Tengfei, et al.
Publicado: (2023)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
por: Baretta, Zora, et al.
Publicado: (2016)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer
por: Yan, Bingbing, et al.
Publicado: (2020)

LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA)
por: Jin, Tong Yi, et al.
Publicado: (2021)

Establishment of a 6-signature risk model associated with cellular senescence for predicting the prognosis of breast cancer
por: Zhang, Xiu-Xia, et al.
Publicado: (2023)

Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese Population
por: Huang, Naisi, et al.
Publicado: (2015)

Identification of an optimized glycolytic-related risk signature for predicting the prognosis in breast cancer using integrated bioinformatic analysis
por: Jiang, Di, et al.
Publicado: (2023)

Changes in HER2 status and survival outcomes in patients with non-pathological complete response after neoadjuvant targeted treatment
por: Ren, Xiaofei, et al.
Publicado: (2023)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Construction and validation of a transient receptor potential-related long noncoding RNA signature for prognosis prediction in breast cancer patients
por: Guo, Qiaonan, et al.
Publicado: (2023)

Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database
por: Plasilova, Magdalena L., et al.
Publicado: (2016)

Impact of Breast Cancer Subtype Defined by Immunohistochemistry Hormone Receptor and HER2 Status on the Incidence of Immediate Postmastectomy Reconstruction
por: Wu, Wei, et al.
Publicado: (2016)

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
por: Tao, Miaomiao, et al.
Publicado: (2017)

ANO6 is a reliable prognostic biomarker and correlates to macrophage polarization in breast cancer
por: Tang, Long-Huan, et al.
Publicado: (2023)

Change of HER2 status during disease recurrence predicts good prognosis for primary squamous cell carcinoma of the breast: A case report
por: Cao, Yong, et al.
Publicado: (2019)

Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab
por: Wang, Xinle, et al.
Publicado: (2019)

Expression of mammalian sterile 20-like kinase 1 and 2 and Yes-associated protein 1 proteins in triple-negative breast cancer and the clinicopathological significance
por: Feng, Yang, et al.
Publicado: (2021)

Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer: An observational study in Asian patients
por: Jung, Eun Jung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c6p04dtb65m5v1j4i12lgp0jdv